EDGAR filings
Every filing EDGAR's full-index lists, from every filer: companies, insiders, funds and filing agents. A search that names no form type, ticker or filer CIK covers at most 31 days and defaults to the last 7.
EDGAR holds what was filed electronically. Electronic filing began in 1993 (the earliest filing here is of 1993-02-11) and was phased in filer by filer until May 1996: filings made on paper before 1993, and during the phase-in by a filer not yet on EDGAR, are not on EDGAR and therefore not here.
50 rows on this page.
| Filed | Form | Filer | Category | 8-K items / description | Accession |
|---|---|---|---|---|---|
| 2023-04-25 | 15-12G |
Sio Gene Therapies Inc.
CIK 1636050
|
Other | 0001636050-23-000028 | |
| 2023-04-24 | EFFECT |
Sio Gene Therapies Inc.
CIK 1636050
|
Registrations and prospectuses | 9999999995-23-001018 | |
| 2023-04-17 | POS AM |
Sio Gene Therapies Inc.
CIK 1636050
|
Registrations and prospectuses | 0001636050-23-000026 | |
| 2023-04-17 | S-8 POS |
Sio Gene Therapies Inc.
CIK 1636050
|
Registrations and prospectuses | 0001636050-23-000024 | |
| 2023-04-12 | 25-NSE |
Sio Gene Therapies Inc.
CIK 1636050
|
Other | 0001354457-23-000271 | |
| 2023-04-06 | 25 |
Sio Gene Therapies Inc.
CIK 1636050
|
Other | 0001636050-23-000017 | |
| 2023-04-06 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders | 0001636050-23-000016 |
| 2023-03-17 | DEFA14A |
Sio Gene Therapies Inc.
CIK 1636050
|
Proxies | 0001636050-23-000013 | |
| 2023-03-15 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 0001636050-23-000011 |
| 2023-02-21 | DEFM14A |
Sio Gene Therapies Inc.
CIK 1636050
|
Proxies | 0001140361-23-007830 | |
| 2023-02-14 | DEFA14A |
Sio Gene Therapies Inc.
CIK 1636050
|
Proxies | 0001636050-23-000009 | |
| 2023-02-14 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001636050-23-000008 |
| 2023-02-14 | 10-Q |
Sio Gene Therapies Inc.
CIK 1636050
|
Financial reports | 10-Q | 0001636050-23-000007 |
| 2023-02-13 | SC 13G/A |
Sio Gene Therapies Inc.
CIK 1636050
|
Ownership | 0000919574-23-000939 | |
| 2023-02-10 | SC 13G |
Sio Gene Therapies Inc.
CIK 1636050
|
Ownership | 0001104659-23-018477 | |
| 2023-02-09 | PREM14A |
Sio Gene Therapies Inc.
CIK 1636050
|
Proxies | 0001140361-23-005279 | |
| 2022-12-14 | DEFA14A |
Sio Gene Therapies Inc.
CIK 1636050
|
Proxies | 0001636050-22-000056 | |
| 2022-12-14 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 8.01 Other Events; 9.01 Financial Statements and Exhibits | 0001636050-22-000054 |
| 2022-11-10 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001636050-22-000051 |
| 2022-11-10 | 10-Q |
Sio Gene Therapies Inc.
CIK 1636050
|
Financial reports | 10-Q | 0001636050-22-000050 |
| 2022-09-14 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 0001636050-22-000043 |
| 2022-08-11 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001636050-22-000041 |
| 2022-08-11 | 10-Q |
Sio Gene Therapies Inc.
CIK 1636050
|
Financial reports | 10-Q | 0001636050-22-000040 |
| 2022-06-14 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001636050-22-000036 |
| 2022-06-14 | 10-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Financial reports | 10-K | 0001636050-22-000035 |
| 2022-04-27 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 1.02 Termination of a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition; 2.05 Costs Associated with Exit or Disposal Activities; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | 0001636050-22-000031 |
| 2022-03-18 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 0001636050-22-000027 |
| 2022-02-14 | SC 13G/A |
Sio Gene Therapies Inc.
CIK 1636050
|
Ownership | 0001085146-22-001038 | |
| 2022-02-11 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001636050-22-000025 |
| 2022-02-11 | 10-Q |
Sio Gene Therapies Inc.
CIK 1636050
|
Financial reports | 10-Q | 0001636050-22-000024 |
| 2022-02-11 | SC 13G/A |
Sio Gene Therapies Inc.
CIK 1636050
|
Ownership | 0000919574-22-000910 | |
| 2022-02-10 | 4 |
Sio Gene Therapies Inc.
CIK 1636050
|
Ownership | 0001636050-22-000021 | |
| 2022-02-10 | 4 |
Sio Gene Therapies Inc.
CIK 1636050
|
Ownership | 0001636050-22-000020 | |
| 2022-02-09 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | 0001636050-22-000015 |
| 2022-02-07 | 3 |
Sio Gene Therapies Inc.
CIK 1636050
|
Ownership | 0001636050-22-000013 | |
| 2022-01-31 | 8-K/A |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 5.07 Submission of Matters to a Vote of Security Holders | 0001636050-22-000011 |
| 2022-01-31 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits | 0001636050-22-000009 |
| 2022-01-25 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 0001636050-22-000002 |
| 2021-12-09 | 4 |
Sio Gene Therapies Inc.
CIK 1636050
|
Ownership | 0001636050-21-000099 | |
| 2021-12-09 | 4 |
Sio Gene Therapies Inc.
CIK 1636050
|
Ownership | 0001636050-21-000098 | |
| 2021-11-12 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001636050-21-000095 |
| 2021-11-12 | 10-Q |
Sio Gene Therapies Inc.
CIK 1636050
|
Financial reports | 10-Q | 0001636050-21-000094 |
| 2021-11-12 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits | 0001636050-21-000091 |
| 2021-11-01 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits | 0001636050-21-000087 |
| 2021-10-21 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 9.01 Financial Statements and Exhibits | 0001636050-21-000084 |
| 2021-10-21 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits | 0001636050-21-000082 |
| 2021-10-06 | S-8 |
Sio Gene Therapies Inc.
CIK 1636050
|
Registrations and prospectuses | 0001636050-21-000079 | |
| 2021-09-24 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits | 0001636050-21-000076 |
| 2021-08-12 | 8-K |
Sio Gene Therapies Inc.
CIK 1636050
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001636050-21-000073 |
| 2021-08-12 | 10-Q |
Sio Gene Therapies Inc.
CIK 1636050
|
Financial reports | 10-Q | 0001636050-21-000072 |